generic times product news

Baclofen Tablets

Marketed by: Caraco Pharmaceutical Laboratories Ltd (Detroit, Mich)

Compared to: Lioresal (Novartis Pharmaceuticals)

Indication: August 16, 2006?Caraco Pharmaceutical announced that the FDA granted final approval for baclofen tablets. Baclofen is a muscle relaxant and antispastic. It is used in the alleviation of signs and symptoms of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.

Dosage Form: Tablets: 10 and 20 mg

For More Information: www.caraco.com 800-818-4555

Bar-coded Suppositories

Marketed by: Paddock Laboratories (Minneapolis, Minn)

Indication: July 5, 2006?Paddock Laboratories has announced the launch of the following suppositories as individually bar-coded to unit-of-use: aspirin 300 and 600 mg; bisacodyl 10 mg; Compro 25 mg (prochlorperazine, USP); hydrocortisone acetate 25 and 30 mg; and hydromorphone HCl 3 mg CII.

For More Information: www.paddocklabs.com 800-328-5113

Diltiazem HCl ER Capsules

Marketed by: ETHEX Corp, a wholly owned subsidiary of KV Pharmaceutical Co (St. Louis, Mo)

Compared to: Tiazac (Forest Pharmaceuticals Inc)

Indication: September 12, 2006?KV Pharmaceutical Co announced that it received FDA approval to market 6 strengths of Diltiazem HCl ER Capsules, through its wholly owned generic/nonbranded subsidiary, ETHEX Corp. With this launch of 6 strengths (120, 180, 240, 300, 360, and 420 mg) of Diltiazem, KV is the first generic company to have a full line of product AB-rated to Tiazac. This product is a calcium channel blocker and may be used to treat high blood pressure, angina, and some arrhythmias.

Dosage Form: Capsules: 120, 180, 240, 300, 360, and 420 mg

For More Information: www.kvpharmaceutical.com

Sertraline Hydrochloride Tablets

Marketed by: Teva Pharmaceuticals (North Wales, Pa)

Compared to: Zoloft (Pfizer Inc)

Indication: August 16, 2006?Teva Pharmaceuticals announced the introduction and availability of sertraline hydrochloride tablets. This product is AB-rated and bioequivalent to Zoloft tablets. The product is indicated for the treatment of major depressive disorder in adults.

Dosage Form: Tablets: 25, 50, and 100 mg

For More Information: www.tevausa.com 888-TEVA-USA (838-2872)

Venlafaxine Hydrochloride Tablets

Marketed by: Teva Pharmaceuticals (North Wales, Pa)

Compared to: Effexor (Wyeth)

Indication: August 4, 2006?Teva Pharmaceuticals announced the introduction and availability of venlafaxine hydrochloride tablets, which are AB-rated and bioequivalent to Effexor tablets. Venlafaxine hydrochloride tablets are indicated for the treatment of major depressive disorder.

Dosage Form: Tablets: 25, 37.5, 50, 75, and 100 mg

For More Information: www.tevausa.com 888-TEVA-USA (838-2872)